Vascular-targeted photodynamic therapy for localized prostate cancer
Thursday, July 29, 2010 - 21:14
in Health & Medicine
NYU Langone Medical Center has begun a clinical trial offering vascular-targeted photodynamic therapy to patients with localized prostate cancer. This novel, minimally invasive procedure uses a light-activated drug to deliver light energy waves by way of laser fibers in order to destroy prostate cancer cells.